Mannitol Challenge Test and Airway Inflammation in COPD
Author Information
Author(s): Selma B de Nijs, Niki Fens, Rene Lutter, Erica Dijkers, Frans H Krouwels, Barbara S Smids-Dierdorp, Reindert P van Steenwijk, Peter J Sterk
Primary Institution: Academic Medical Centre and University of Amsterdam
Hypothesis
AHR to inhaled mannitol captures eosinophilia in induced sputum in COPD.
Conclusion
Mannitol hyperresponsiveness is associated with biomarkers of airway inflammation in mild-moderate COPD.
Supporting Evidence
- There was a positive correlation between RDR to mannitol and eosinophil numbers.
- Significant correlations were found between RDR and levels of ECP, IL-8, and MPO in sputum.
- ROC-curves showed 60% sensitivity and 100% specificity of RDR for >2.5% eosinophils in mannitol-induced sputum.
Takeaway
The study found that a test using mannitol can help identify inflammation in the lungs of COPD patients, which can guide their treatment.
Methodology
The study involved 28 patients with mild-moderate COPD who underwent mannitol challenge and sputum collection to assess airway inflammation.
Potential Biases
Potential inclusion of patients with undiagnosed asthma despite exclusion criteria.
Limitations
Some patients could not provide adequate sputum samples, and the study may not generalize to COPD patients on inhaled corticosteroids.
Participant Demographics
28 patients, mean age 58 years, 23 males and 5 females, with a smoking history of 40 pack-years.
Statistical Information
P-Value
0.001
Confidence Interval
95% CI, 33.6 to 97.5%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website